← Leaderboards
Russell Devore
Vanderbilt University
$0
Attributed
$0
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 1
By mechanism
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Jennifer A Pietenpol$43,416,854
- Neil Osheroff$12,336,075
- Roy A. Jensen$20,860,843
- Jordan D Berlin$14,361,518
- Pierre P Massion$18,568,000
Others in their field
Top investigators on “Alkyltransferase”
- Stanton L Gerson · Case Western Reserve University$8,072,527
- Anthony E Pegg · Pennsylvania State Univ Hershey Med Ctr$6,639,817
- F Peter Guengerich · Vanderbilt University$5,830,084
- Alan Clayton Sartorelli · Yale University$5,801,192
- Henry S. Friedman · Duke University$4,525,323
- John A Tainer · Scripps Research Institute$4,372,892
Research focus
AlkyltransferaseAntineoplasticsCarboplatinClinical ResearchClinical Trial Phase ICombination ChemotherapyEnzyme InhibitorsHuman SubjectHuman Therapy EvaluationLaminsLung NeoplasmsNeoplasm /Cancer ChemotherapyOral AdministrationPaclitaxelPharmacokinetics
Grant awards (5)
R115777 IN COMBI W/ PACLITAXEL &CARBOPLATIN IN INCURABLE CANCER$0
M01 · FY2002 · RR
R115777 IN COMBI W/ PACLITAXEL &CARBOPLATIN IN INCURABLE CANCER$0
M01 · FY2001 · RR
R115777 IN COMBI W/ PACLITAXEL &CARBOPLATIN IN INCURABLE CANCER$0
M01 · FY2001 · RR
R115777 IN COMBI W/ PACLITAXEL &CARBOPLATIN IN INCURABLE CANCER$0
M01 · FY2001 · RR
R115777 IN COMBI W/ PACLITAXEL &CARBOPLATIN IN INCURABLE CANCER$0
M01 · FY2000 · RR